Error: Could not add to watchlist. X
+ Watchlist

CytRx Corp

CYTR:US
NASDAQ CM
0.67
USD
0.02
3.08%
As of 8:10 PM EDT 6/23/2017
Open
0.70
Day Range
0.67 - 0.76
Volume
19,565,088
Previous Close
0.69
52Wk Range
0.36 - 2.67
1 Yr Return
-71.62%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
0.70
Day Range
0.67 - 0.76
Volume
19,565,088
Previous Close
0.69
52Wk Range
0.36 - 2.67
1 Yr Return
-71.62%
YTD Return
80.74%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.58
Market Cap (m USD)
102.287
Shares Outstanding (m)
152.055
Price/Sales (TTM)
270.11
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.09%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
CytRx Corporation is a biopharmaceutical research and development company. The Company focuses in the development of high-value human therapeutics, specializing in oncology. CytRx is also developing two drug candidates based on its molecular chaperone regulation technology.
Address
11726 San Vicente Boulevard
Suite 650
Los Angeles, CA 90049
United States
Phone
1-310-826-5648
  • Steven A Kriegsman
    Chairman/President/CEO
  • Jean-Yves Caloz "John"
    CFO/Treasurer
  • Olivia Ware
    Chief Commercial Officer
  • Daniel J Levitt
    Exec VP/COO/Chief Medical Ofcr
  • Shanta Chawla
    VP:Clinical Development
Show More